According to a new report, published by KBV research, The Global Corneal Implants Market size is expected to reach $595.1 Million by 2029, rising at a market growth of 6.4% CAGR during the forecast period.
The Keratoconus segment is showcasing a CAGR of 6.7% during (2023 - 2029). This is because it is a common eye condition that alters the cornea's structure and frequently causes vision loss. Business trends will pick up speed as more people become aware of corneal transplantation as a successful method for helping persons with the ailment regain their sight. Also, the aging population and the incapacity of keratoconus corneas to combat oxidative stress brought on by UV radiation may further increase the segment's growth.
The Penetrating Keratoplasty segment is leading the Global Corneal Implants Market by Procedure Type in 2022 thereby, achieving a market value of $328.4 million by 2029. This is due to the successful visual outcomes and high survival rate of all corneal transplantation purposes. Penetrating keratoplasty is also the most used method for corneal transplantation. The rising number of persons with eye injuries and eye conditions is one of the main causes of the expansion of penetrating keratoplasty.
The Ophthalmic Centers segment has shown the growth rate of 6.9% during (2023 - 2029). This is because the shorter wait times, a rise in the number of ophthalmologists entering practice, and a growing acceptance of keratoprosthetics are all predicted to contribute to the segment's growth. Ophthalmic centers are knowledgeable about local elements that could impact the patient's eye health, such as local allergies and helpful product locations. Also, they can provide precise directions on where to buy the eye drops or contact solution the patient requires.
The North America market dominated the Global Corneal Implants Market by Region in 2022, and would continue to be a dominant market till 2029; thereby, achieving a market value of $240 million by 2029. The Europe market is exhibiting a CAGR of 5.9% during (2023 - 2029). Additionally, The Asia Pacific market would showcase a CAGR of 7.2% during (2023 - 2029).
Full Report: https://www.kbvresearch.com/corneal-implants-market/
The market research report has exhaustive quantitative insights providing a clear picture of the market potential in various segments across the globe with country wise analysis in each discussed region. The key impacting factors of the market have been discussed in the report with the elaborated company profiles of Presbia PLC, CorNeat Vision Ltd., Alcon, Inc., AJL Opthalmic SA, LinkoCare Life Sciences AB, CorneaGen, DIOPTEX GmbH, Mediphacos Industrias Medicas S.A., EyeYon Medical Ltd., and KeraMed, Inc.
By Disease Type
By Procedure Type
By End User
By Geography
Companies Profiled
Unique Offerings 
